Rare epidermal growth factor receptor (EGFR) mutations in completely resected stage I lung adenocarcinoma: a real-world study of mutation spectrum, clinicopathological features, and prognosis
- DOI
- 10.21037/tlcr-2026-0953
- Published
- 2026-10
- Container
- Translational Lung Cancer Research
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/tlcr-2026-0953,
title = {Rare epidermal growth factor receptor (EGFR) mutations in completely resected stage I lung adenocarcinoma: a real-world study of mutation spectrum, clinicopathological features, and prognosis},
author = {Lajie Man and Liang Xia and Chuan Li and Xiaohu Hao and Xiaolong Zhang and Ruichen Cui and Chenglin Guo and Yafei Xie and Jiahan Cheng and Chengwu Liu and Lunxu Liu},
year = {2026},
journal = {Translational Lung Cancer Research},
doi = {10.21037/tlcr-2026-0953},
url = {https://doi.org/10.21037/tlcr-2026-0953}
}RIS
TY - JOUR TI - Rare epidermal growth factor receptor (EGFR) mutations in completely resected stage I lung adenocarcinoma: a real-world study of mutation spectrum, clinicopathological features, and prognosis AU - Lajie Man AU - Liang Xia AU - Chuan Li AU - Xiaohu Hao AU - Xiaolong Zhang AU - Ruichen Cui AU - Chenglin Guo AU - Yafei Xie AU - Jiahan Cheng AU - Chengwu Liu AU - Lunxu Liu PY - 2026 JO - Translational Lung Cancer Research DO - 10.21037/tlcr-2026-0953 UR - https://doi.org/10.21037/tlcr-2026-0953 ER -
APA
Man, L., Xia, L., Li, C., Hao, X., Zhang, X., Cui, R., Guo, C., Xie, Y., Cheng, J., Liu, C., & Liu, L. (2026). Rare epidermal growth factor receptor (EGFR) mutations in completely resected stage I lung adenocarcinoma: a real-world study of mutation spectrum, clinicopathological features, and prognosis. Translational Lung Cancer Research. https://doi.org/10.21037/tlcr-2026-0953
Source records
- crossref · retrieved 2026-11-10T13:09:03.509Z